vs
AMICUS THERAPEUTICS, INC.（FOLD）与弗雷斯特研究公司（FORR）财务数据对比。点击上方公司名可切换其他公司
AMICUS THERAPEUTICS, INC.的季度营收约是弗雷斯特研究公司的1.8倍（$185.2M vs $101.1M），AMICUS THERAPEUTICS, INC.净利率更高（0.9% vs -33.5%，领先34.4%），AMICUS THERAPEUTICS, INC.同比增速更快（23.7% vs -6.5%），AMICUS THERAPEUTICS, INC.自由现金流更多（$16.0M vs $-4.3M），过去两年AMICUS THERAPEUTICS, INC.的营收复合增速更高（29.5% vs 0.5%）
Amicus Therapeutics是总部位于美国宾夕法尼亚州费城的生物制药上市企业，2007年在纳斯达克挂牌上市，股票代码为FOLD。上市前，公司曾获得Radius Ventures、迦南合伙人、恩颐投资等多家风险投资机构的资金支持，专注于生物医药领域的研发与商业化布局。
福雷斯特研究公司是一家全球领先的研究咨询机构，主营业务涵盖行业研究、管理咨询与行业峰会举办，客户群体包括全球大型企业、科技公司与消费领域领军企业，公司总部位于美国马萨诸塞州剑桥市。
FOLD vs FORR — 直观对比
营收规模更大
FOLD
是对方的1.8倍
$101.1M
营收增速更快
FOLD
高出30.2%
-6.5%
净利率更高
FOLD
高出34.4%
-33.5%
自由现金流更多
FOLD
多$20.2M
$-4.3M
两年增速更快
FOLD
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.2M | $101.1M |
| 净利润 | $1.7M | $-33.9M |
| 毛利率 | 85.7% | 56.7% |
| 营业利润率 | 8.6% | -36.6% |
| 净利率 | 0.9% | -33.5% |
| 营收同比 | 23.7% | -6.5% |
| 净利润同比 | -88.5% | -7941.4% |
| 每股收益（稀释后） | $0.00 | $-1.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FOLDFORR
| Q4 25 | $185.2M | $101.1M | ||
| Q3 25 | $169.1M | $94.3M | ||
| Q2 25 | $154.7M | $111.7M | ||
| Q1 25 | $125.2M | $89.9M | ||
| Q4 24 | $149.7M | $108.0M | ||
| Q3 24 | $141.5M | $102.5M | ||
| Q2 24 | $126.7M | $121.8M | ||
| Q1 24 | $110.4M | $100.1M |
净利润FOLDFORR
| Q4 25 | $1.7M | $-33.9M | ||
| Q3 25 | $17.3M | $-2.1M | ||
| Q2 25 | $-24.4M | $3.9M | ||
| Q1 25 | $-21.7M | $-87.3M | ||
| Q4 24 | $14.7M | $432.0K | ||
| Q3 24 | $-6.7M | $-5.8M | ||
| Q2 24 | $-15.7M | $6.3M | ||
| Q1 24 | $-48.4M | $-6.7M |
毛利率FOLDFORR
| Q4 25 | 85.7% | 56.7% | ||
| Q3 25 | 88.5% | 60.0% | ||
| Q2 25 | 90.2% | 55.5% | ||
| Q1 25 | 90.7% | 55.9% | ||
| Q4 24 | 90.1% | 58.8% | ||
| Q3 24 | 90.6% | 60.5% | ||
| Q2 24 | 91.1% | 57.3% | ||
| Q1 24 | 87.7% | 54.9% |
营业利润率FOLDFORR
| Q4 25 | 8.6% | -36.6% | ||
| Q3 25 | 20.3% | 4.7% | ||
| Q2 25 | -6.1% | 6.2% | ||
| Q1 25 | -6.3% | -97.5% | ||
| Q4 24 | 10.7% | -0.5% | ||
| Q3 24 | 15.3% | -0.7% | ||
| Q2 24 | 11.8% | 9.3% | ||
| Q1 24 | -25.1% | -9.3% |
净利率FOLDFORR
| Q4 25 | 0.9% | -33.5% | ||
| Q3 25 | 10.2% | -2.3% | ||
| Q2 25 | -15.8% | 3.5% | ||
| Q1 25 | -17.3% | -97.1% | ||
| Q4 24 | 9.8% | 0.4% | ||
| Q3 24 | -4.8% | -5.7% | ||
| Q2 24 | -12.4% | 5.2% | ||
| Q1 24 | -43.9% | -6.7% |
每股收益（稀释后）FOLDFORR
| Q4 25 | $0.00 | $-1.75 | ||
| Q3 25 | $0.06 | $-0.11 | ||
| Q2 25 | $-0.08 | $0.20 | ||
| Q1 25 | $-0.07 | $-4.62 | ||
| Q4 24 | $0.05 | $0.02 | ||
| Q3 24 | $-0.02 | $-0.30 | ||
| Q2 24 | $-0.05 | $0.33 | ||
| Q1 24 | $-0.16 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $293.5M | $63.3M |
| 总债务越低越好 | $392.7M | — |
| 股东权益账面价值 | $274.2M | $126.5M |
| 总资产 | $949.9M | $404.0M |
| 负债/权益比越低杠杆越低 | 1.43× | — |
8季度趋势，按日历期对齐
现金及短期投资FOLDFORR
| Q4 25 | $293.5M | $63.3M | ||
| Q3 25 | $263.8M | $65.1M | ||
| Q2 25 | $231.0M | $67.8M | ||
| Q1 25 | $250.6M | $75.6M | ||
| Q4 24 | $249.9M | $56.1M | ||
| Q3 24 | $249.8M | $62.8M | ||
| Q2 24 | $260.1M | $58.9M | ||
| Q1 24 | $239.6M | $61.4M |
总债务FOLDFORR
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
股东权益FOLDFORR
| Q4 25 | $274.2M | $126.5M | ||
| Q3 25 | $230.4M | $157.7M | ||
| Q2 25 | $204.3M | $159.5M | ||
| Q1 25 | $193.6M | $147.4M | ||
| Q4 24 | $194.0M | $229.5M | ||
| Q3 24 | $178.8M | $234.3M | ||
| Q2 24 | $132.5M | $237.1M | ||
| Q1 24 | $130.7M | $230.9M |
总资产FOLDFORR
| Q4 25 | $949.9M | $404.0M | ||
| Q3 25 | $868.8M | $414.2M | ||
| Q2 25 | $815.3M | $436.0M | ||
| Q1 25 | $789.8M | $439.8M | ||
| Q4 24 | $785.0M | $503.9M | ||
| Q3 24 | $786.6M | $505.3M | ||
| Q2 24 | $749.5M | $524.2M | ||
| Q1 24 | $721.8M | $555.7M |
负债/权益比FOLDFORR
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.3M | $-3.2M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $-4.3M |
| 自由现金流率自由现金流/营收 | 8.6% | -4.2% |
| 资本支出强度资本支出/营收 | 0.2% | 1.1% |
| 现金转化率经营现金流/净利润 | 9.62× | — |
| 过去12个月自由现金流最近4个季度 | $29.8M | $18.1M |
8季度趋势，按日历期对齐
经营现金流FOLDFORR
| Q4 25 | $16.3M | $-3.2M | ||
| Q3 25 | $35.7M | $1.2M | ||
| Q2 25 | $-26.5M | $-3.6M | ||
| Q1 25 | $7.8M | $26.7M | ||
| Q4 24 | $-3.9M | $-1.8M | ||
| Q3 24 | $-23.0M | $264.0K | ||
| Q2 24 | $22.7M | $-2.9M | ||
| Q1 24 | $-29.7M | $611.0K |
自由现金流FOLDFORR
| Q4 25 | $16.0M | $-4.3M | ||
| Q3 25 | $35.3M | $524.0K | ||
| Q2 25 | $-28.9M | $-4.2M | ||
| Q1 25 | $7.5M | $26.1M | ||
| Q4 24 | $-4.2M | $-2.5M | ||
| Q3 24 | $-23.3M | $-223.0K | ||
| Q2 24 | $21.6M | $-3.7M | ||
| Q1 24 | $-31.5M | $-815.0K |
自由现金流率FOLDFORR
| Q4 25 | 8.6% | -4.2% | ||
| Q3 25 | 20.9% | 0.6% | ||
| Q2 25 | -18.7% | -3.8% | ||
| Q1 25 | 6.0% | 29.0% | ||
| Q4 24 | -2.8% | -2.3% | ||
| Q3 24 | -16.5% | -0.2% | ||
| Q2 24 | 17.0% | -3.1% | ||
| Q1 24 | -28.5% | -0.8% |
资本支出强度FOLDFORR
| Q4 25 | 0.2% | 1.1% | ||
| Q3 25 | 0.2% | 0.7% | ||
| Q2 25 | 1.6% | 0.5% | ||
| Q1 25 | 0.2% | 0.7% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.9% | 0.7% | ||
| Q1 24 | 1.6% | 1.4% |
现金转化率FOLDFORR
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | -0.93× | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | -4.24× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.46× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
FORR
| Research Segment | $82.2M | 81% |
| Consulting Segment | $16.2M | 16% |
| Billable Expenses | $1.5M | 2% |
| Professional Services | $1.4M | 1% |
